Skip to main content

Table 4 The mRNA expression level (copies/μg of total RNA) of target genes in different group of samples

From: Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate

 

Expression level (copies/μg of total RNA)

Target genes

CP-Be (n = 7)

CP-PCa (n = 12)

RP-Be (n = 69)

RP-PCa (n = 69)

KLK3

1 × 109 (4.6 × 106, 3.2 × 1010)

1.2 × 109(7.8 × 106, 9.9 × 1010)

3.2 × 109(7.8 × 107,2.6 × 1012)

2.1 × 109(9.9 × 107,3.1 × 1013)

AMACR

0 (0, 2.7 × 104)

3.5 × 105(8.1 × 103,4.2 × 106)

7 × 106(6.2 × 102,4.1 × 1010)

8.3 × 106(1 × 103,1.5 × 1010)

AR

5.1 × 104 (7.8 × 103, 1,2 × 106)

1 × 105(4.4 × 104,1.1 × 106)

5.6 × 105(1.7 × 104,6.2 × 107)

5.5 × 105(1 × 104,6.5 × 107)

  1. Data are presented as median (min, max). CP-Be represents cystoprostatectomy samples with no evidence of PCa, CP-PCa represents cystoprostatectomy samples with incidental PCa, RP-Be represent histologically benign samples from radical prostatectomy specimens and RP-PCa represents cancerous samples from radical prostatectomy specimens
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us